Pamela S. Ohashi
Toronto, ON M5T3M6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 194 publications
Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: February 18, 2026
B cells drive CD4 T cell immunosenescence and age-associated health decline.
Journal: Science immunology
Published: January 30, 2026
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 23, 2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.
Journal: Therapeutic advances in medical oncology
Published: May 12, 2025
Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma.
Journal: Genome medicine
Published: December 30, 2024
Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer.
Journal: Science advances
Published: October 30, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.
Journal: JCO precision oncology
Published: August 23, 2024
Last Updated: 09/26/2026